Medical network on March 29 - a "zhuhai college of medical consumables reagent two votes manufacturer communication meeting invitation" began to appear in many professional medical devices WeChat group, which started from zhuhai consumables, reagents of two votes are just a few days. 

 

This also means that after the two votes, aimed at the battle of distribution market is coming! 

 

Invite manufacturers to hold this communication is not a general medical device makers, but famous kyushu, guangdong jiuzhou tong. 

 

Just published in 2016 in zhuhai zhuhai college medical consumables distribution enterprise selection results, jiuzhou group of three companies made including ophthalmic consumables group, the dialyzer and dialysis line group, intervention class supplies, test reagents (including pathological reagent) and blood stations with consumables, orthopaedic apparatus, cardiac pacing and some are involved in the distribution of product groups, obtain four ranked first. 

 

Zhuhai has been one of medical reform "leading role", is the guangdong zhuhai jiuzhou hinterland of the marketing. Years of intensive cultivation, the realization of public medical institution 100% coverage, zhuhai area with public health care and private health care, terminal retail chain of more than 800 guests, operating more than 4100 11000 well-known varieties of upstream suppliers. Guangdong jiuzhou since it was founded in 2002, has grown into annual sales of 6 billion largest private medicine circulation enterprises in guangdong province. 

 

For the communication meeting will be held in April, guangdong jiuzhou said, the purpose is to strengthen friends in-depth cooperation with the manufacturers, promote kyushu cooperation strategy. But everybody can see, the increased marketing efforts, for more powerful business. 

 

With the ground material of two votes policy, each big YaoXie circulation enterprises fight for market distribution rights will be inevitable, and the two votes policy to the requirement of commercial distribution, apparently more conducive to large YaoXie circulation enterprises, because of the large pharmaceutical enterprise internal circulation transfers is not a ticket once (up), all show. 

 

But at this point, coupled with the big company extensive distribution network, will no doubt win from the market. A large number of small and medium-sized YaoXie circulation enterprises, due to two votes policy are fall to the ground and the loss of market, were out. From already landed two votes distributors around the consumables, China resources, prescription, kyushu basic become regulars, the penetration, different regions have other distributors to participate in, to form the pattern of "3 + N".